Inguran v. ABS Global & Genus PLC: Sexed Semen Patent Dispute Ends After 1,449 Days
ST Genetics (Inguran, LLC) brought a patent infringement action against ABS Global and its parent Genus PLC in Wisconsin, asserting US8206987B2 covering sexed semen AI straw technology. After nearly four years of litigation, all claims and counterclaims were dismissed with prejudice by joint stipulation, with each party bearing its own costs.
ST Genetics vs. ABS Global: A Four-Year Battle Over Bovine AI Patent Rights
On January 29, 2020, Inguran, LLC — operating under the brand ST Genetics — filed suit against ABS Global, Inc. and its UK-based parent Genus PLC in the Western District of Wisconsin (Case No. 3:20-cv-00085). The case centred on US8206987B2, a patent covering sexed semen artificial insemination straw technology used in bovine reproduction. At issue was ABS Global’s Intelligen GSS system, which ST alleged enabled third-party bull studs to produce and use sexed semen AI straws in a manner that infringed ST’s patent rights, including a disputed single-use restriction limiting each straw to inseminating one female bovine.
The case closed on January 17, 2024, when both sides executed a stipulated dismissal under Fed. R. Civ. P. 41(a), dismissing all claims and counterclaims with prejudice and with each party bearing its own fees. Dismissal with prejudice is final — neither party may refile the same claims — and the mutual fee arrangement suggests a negotiated resolution rather than a clear-cut capitulation by either side. The absence of a merits ruling means no court-issued claim construction or validity determination is on the public record.
The 1,449-day duration is consistent with a complex, commercially significant dispute involving both infringement claims and counterclaims — suggesting ABS mounted a robust invalidity or non-infringement defence, likely including inter partes review or claim construction battles. The Intelligen GSS system’s market reach into dairy and beef farming makes the IP stakes high for both parties. What drove the ultimate settlement — licensing terms, commercial pressure, or litigation cost — remains undisclosed from the public record.
Filing to Dismissed with Prejudice in 1449 days
1,449 days — nearly four years, well above the median district court patent case duration
Dismissed with prejudice: what the stipulated exit means for both parties
Rule 41(a) stipulated dismissal with prejudice explained
A Rule 41(a) dismissal by stipulation requires both parties’ signatures, making it a consensual exit. ‘With prejudice’ means all claims and counterclaims are permanently extinguished — neither Inguran nor ABS/Genus can refile the same assertions arising from these facts. This is the functional equivalent of a final judgment on the merits for claim-preclusion purposes, even though no court ever ruled on infringement or validity.
Claim-preclusive dismissalST Genetics relinquishes infringement claims permanently
By agreeing to dismissal with prejudice, Inguran/ST Genetics cannot re-assert US8206987B2 against ABS Global or Genus PLC for conduct covered by this litigation. Whether this reflects a licensing deal, a commercial arrangement, or pure litigation fatigue is not disclosed. The each-party-bears-own-costs term is consistent with a negotiated settlement rather than a plaintiff capitulation.
Claims permanently waivedABS Global and Genus PLC exit without invalidity ruling
ABS and Genus PLC secured a dismissal of all ST claims with prejudice, eliminating ongoing litigation risk from this action. However, the dismissal also extinguishes their counterclaims — meaning any invalidity arguments they raised against US8206987B2 were dropped without a court ruling. The patent therefore survives unchallenged in this proceeding, which could matter if ST pursues other infringers.
Counterclaims also dismissedBovine genetics IP landscape: US8206987B2 remains live and unchallenged
Because no court ruled on validity or infringement, US8206987B2 emerges from this litigation with its presumption of validity intact. Competitors operating sexed semen platforms or AI straw distribution systems similar to the Intelligen GSS model should treat this patent as an active enforcement risk. The single-use AI restriction language is particularly notable — product design choices around straw usage protocols may determine future infringement exposure.
Patent presumption of validity intactFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Inguran, LLC | Company | Bovine genetics and sexed semen licensor — holder of US8206987B2Search in Eureka ↗ |
| Defendant | ABS Global, Inc. | Company | ABS Global, Inc. (Genus PLC subsidiary) — bovine genetics and Intelligen GSS system providerSearch in Eureka ↗ |
| Co-Defendant | Genus, PLC | Company | Search in Eureka ↗ |
| Plaintiff counsel | Clayton Nicholas Matheson | Attorney | Counsel for Inguran, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Daniel L. Moffett | Attorney | Counsel for Inguran, LLCSearch in Eureka ↗ |
| Plaintiff counsel | George Andrew Rosbrook | Attorney | Counsel for Inguran, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Kirt Stephen O’Neill | Attorney | Counsel for Inguran, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Megan Mahoney | Attorney | Counsel for Inguran, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Sarah Anne Zylstra | Attorney | Counsel for Inguran, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Thomas Watson Landers , IV | Attorney | Counsel for Inguran, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Akin Gump Strauss Hauer & Feld LLP | Law Firm | Representing Inguran, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Boardman & Clark LLP | Law Firm | Representing Inguran, LLCSearch in Eureka ↗ |
| Defendant counsel | Brooke Shanelle Boll | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Bryan Clifford Mulder | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Jason Phillip Greenhut | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Justin Harold Lessner | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Kevin Robert Oliver | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Michael J. Modl | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Neil H. Conrad | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Paul Rogerson | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Richard M. Chen | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Stephanie P. Koh | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Steven Joseph Horowitz | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant counsel | Thomas D. Rein | Attorney | Counsel for ABS Global, Inc.Search in Eureka ↗ |
| Defendant law firm | Axley Brynelson, LLP | Law Firm | Representing ABS Global, Inc.Search in Eureka ↗ |
| Defendant law firm | Chicago-kent College Of Law | Law Firm | Representing ABS Global, Inc.Search in Eureka ↗ |
| Defendant law firm | Kelley Drye & Warren LLP | Law Firm | Representing ABS Global, Inc.Search in Eureka ↗ |
| Defendant law firm | Sidley Austin LLP | Law Firm | Representing ABS Global, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Wisconsin Western District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulated dismissal language is precise in its bilateral scope: all claims and all counterclaims are dismissed with prejudice, with no carve-outs. The equal cost-bearing provision is notable — fee-shifting under 35 U.S.C. § 285 requires a finding of an ‘exceptional case,’ and its absence here is consistent with a negotiated exit rather than a merits-based resolution. No court construed the claims of US8206987B2, and no validity finding was entered, meaning the patent’s enforceability posture is unchanged by this proceeding.
US8206987B2 — Sexed Semen Artificial Insemination Straw Technology
US8206987B2, filed under application number US13/106671, protects technology relating to sexed semen packaged in artificial insemination straws for bovine reproduction. The patent covers compositions and methods associated with sexed semen doses formulated at sperm concentrations suited for AI, and critically includes claim language directed to a single-use restriction — limiting each straw to the insemination of one female bovine for producing a single offspring. This restriction is commercially significant as it governs how downstream users — including bull studs operating under GSS platform licences — may deploy the technology.
In the bovine genetics sector, sexed semen commands a price premium and underpins competitive differentiation for major genetics companies. US8206987B2 gives ST Genetics a potential enforcement mechanism not just against direct competitors but against platform providers like ABS Global who supply machinery, protocols, and training to third-party bull studs. The patent’s survival without an invalidity ruling following this litigation strengthens ST’s ability to assert it in future actions, raising the bar for any competitor seeking to design around or challenge its claims.
Should you run an FTO analysis against US8206987B2?
Any company involved in the production, distribution, or licensing of sexed semen AI straw technology — particularly those operating GSS-style platforms, supplying bull studs, or developing AI protocols for bovine reproduction — should conduct a freedom-to-operate analysis against US8206987B2. The case established that ST Genetics is prepared to litigate this patent aggressively, and the single-use restriction language creates a specific tripwire for platform providers who train or instruct third parties in straw usage.
PatSnap Eureka’s FTO Search Agent can map the claim scope of US8206987B2 against your specific product or process, identify prior art that may inform validity assessments, and flag related ST Genetics patents in the same technology family. R&D and product teams designing AI straw protocols or GSS platform documentation should run an FTO before finalising usage instructions, training materials, or licensing structures — the induced infringement risk under these claim terms is commercially material.
Run a freedom-to-operate analysis on US8206987B2 to assess your product’s exposure
Run FTO in Eureka →Similar patent cases: sexed semen and bovine AI technology disputes
Explore related infringement actions involving sexed semen, artificial insemination IP, and animal genetics patents litigated in US district courts.
What this case signals for the bovine genetics and animal reproduction IP landscape
A four-year dispute ending in mutual dismissal suggests high commercial stakes and a negotiated resolution that keeps key terms private.
US8206987B2 survives — no invalidity ruling means ongoing enforcement risk
ABS Global’s counterclaims — likely including invalidity challenges — were dismissed without adjudication. The patent therefore retains its full presumption of validity. Any company operating in sexed semen AI straw technology should conduct a freedom-to-operate analysis against US8206987B2 before scaling commercial operations or licensing the Intelligen model.
Single-use restriction language is a key infringement tripwire to monitor
The ‘single use AI’ restriction — limiting each straw to inseminating one female bovine — was central to the product allegations. Companies designing AI straw protocols, usage instructions, or GSS-style platforms should carefully assess whether their operational documentation and training materials create induced infringement exposure under this claim scope.
Inguran v ABS — key questions answered
The case was dismissed with prejudice by joint stipulation under Fed. R. Civ. P. 41(a) on January 17, 2024, with each party bearing its own costs. All claims by Inguran/ST Genetics and all counterclaims by ABS Global and Genus PLC were permanently extinguished. No court ruling on infringement or patent validity was issued.
Inguran asserted US8206987B2 (application no. US13/106671), a patent covering sexed semen artificial insemination straw technology for bovine reproduction, including a single-use restriction limiting each straw to the insemination of one female bovine for producing a single offspring.
Dismissal with prejudice means ABS Global’s counterclaims — which likely included invalidity challenges — were dropped without adjudication. US8206987B2 therefore retains its statutory presumption of validity under 35 U.S.C. § 282. No court construed its claims or found any claim invalid, leaving the patent’s enforceability posture unchanged.
Genus PLC, the UK-listed parent of ABS Global, was named as a co-defendant — consistent with ST Genetics pursuing indirect or contributory infringement claims up the corporate structure. The public record does not disclose the specific legal theory applied to Genus PLC, but its inclusion suggests ST sought to hold the corporate parent liable for ABS’s alleged infringing activities.
The Intelligen GSS system is a platform supplied by ABS Global to third-party bull studs, comprising machinery, usage protocols, and operator training for producing sexed semen AI straws. ST Genetics alleged that ABS’s supply of this system — including instructions and training — constituted infringement of US8206987B2, raising potential induced infringement claims based on how downstream bull studs used the technology.
PatSnap Eureka searches patents and litigation data to answer instantly.